Astrana Health Inc. (NASDAQ: ASTH) has emerged as an intriguing prospect in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $1.13 billion, this..
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands as a beacon in the biotechnology sector, renowned for its focus on developing therapies for rare and ultra-rare genetic diseases. Headquartered in Novato, California,..
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) presents an intriguing opportunity for investors in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a current market capitalization of..
Immunocore Holdings plc (NASDAQ: IMCR) stands at the forefront of biotechnology innovation, specializing in pioneering immunotherapies for the treatment of oncology, infectious, and autoimmune diseases. Headquartered in Abingdon, United Kingdom,..
BGM Group Ltd. (BGM), a healthcare sector player in the drug manufacturing industry, has caught the attention of investors despite its recent financial challenges. Based in Chengdu, China, the company..
For investors seeking opportunities in the healthcare sector, NovoCure Limited (NASDAQ: NVCR) presents a compelling case with its significant potential upside of 98.95%, as indicated by analyst ratings. Specializing in..
Ardent Health, Inc. (ARDT), a prominent player in the U.S. healthcare sector, focuses on delivering comprehensive medical services through its extensive network of hospitals and clinics. With a market capitalization..
Bausch Health Companies Inc. (NYSE: BHC), a prominent player in the healthcare sector with a specific focus on drug manufacturing, presents an intriguing opportunity for investors seeking exposure in the..
Liquidia Corporation (NASDAQ: LQDA) has emerged as a noteworthy contender in the biotechnology sector, capturing investor attention with its remarkable revenue growth and substantial market cap of $2.6 billion. Based..
Brookdale Senior Living Inc. (NYSE: BKD) stands as a prominent player within the medical care facilities industry, residing under the broad umbrella of the healthcare sector. With a market capitalization..
QuidelOrtho Corporation (NASDAQ: QDEL) is an intriguing player in the healthcare sector, particularly within the medical devices industry. With a current market capitalization of $1.81 billion, the company offers a..
Twist Bioscience Corporation (NASDAQ: TWST) stands at the forefront of innovation in the healthcare sector, specifically within the diagnostics and research industry. Based in South San Francisco, California, this biotech..
Vera Therapeutics, Inc. (NASDAQ: VERA) is making waves in the biotechnology sector with its promising pipeline of immunological treatments, attracting significant attention from investors. Headquartered in Brisbane, California, this clinical-stage..
Vericel Corporation (NASDAQ: VCEL) presents a unique opportunity in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $1.97 billion, Vericel has established itself as a..
Surgery Partners, Inc. (NASDAQ: SGRY), a prominent player in the healthcare sector specializing in medical care facilities, presents an intriguing opportunity for investors seeking exposure to the healthcare industry’s growth..
GoodRx Holdings, Inc. (NASDAQ: GDRX), a prominent player in the health information services sector, stands out as a compelling investment opportunity with a potential upside of 83.73%, according to analysts’..
ICU Medical, Inc. (NASDAQ: ICUI), a key player in the healthcare sector specializing in medical instruments and supplies, has captured investor attention with a promising potential upside of 21.74%. Based..
Biohaven Ltd. (BHVN), a burgeoning player in the biotechnology sector, is capturing investor attention with its ambitious pipeline of treatments targeting critical areas like neuroscience, oncology, and immunology. With a..
Addus HomeCare Corporation (NASDAQ: ADUS) is drawing significant attention from investors, particularly within the healthcare sector. With a market capitalization of $2.14 billion, this Frisco, Texas-based company is carving out..
89bio, Inc. (ETNB), a promising clinical-stage biopharmaceutical company focused on liver and cardio-metabolic diseases, has caught the attention of investors with its significant potential upside. Operating in the dynamic biotechnology..
